Bangladesh

You are here:-Bangladesh
Bangladesh2018-11-11T11:55:57+00:00

TB remains a major public health problem in Bangladesh. The country ranks fourth in the world for both prevalences of TB and TB mortalities. It is estimated that about 81,000 people died in 2014 due to TB. In 2014, WHO reported 196,797 TB cases were notified to the national registry, 187,005 of which were new cases. Case notification rate of all forms of TB is low at 53%. Although there is no estimate of the prevalence of childhood TB, it is believed that childhood TB is severely under-diagnosed. MDR TB is an emerging threat in Bangladesh. According to WHO estimates, MDR-TB rate among all newly diagnosed cases is estimated at 1.4%, and among previously treated cases at 22%.

The TB CARE II Bangladesh project is a field support activity funded through the USAID TB CARE II Project, which is a cooperative agreement awarded to the URC led consortium in September 2010. The project, drawing on the Global Fund and the Government of Bangladesh expert resources, facilitates implementation of strategies to strengthen and expand TB DOTS, Programmatic Management of Drug Resistant TB (PMDT) programs, and health systems.

Aligned with National TB Control Programme strategic objectives and USAID/Dhaka strategic framework, the TB CARE II partnership’s activities complement the Global Fund and Government of Bangladesh efforts to strengthen all the components of Stop TB Strategy with a major emphasis on universal and early access to TB services, Programmatic Management of Drug Resistant TB (PMDT), and health systems strengthening.

The TB CARE II Project has made significant achievements in fighting against TB in Bangladesh. Key achievements include improved access to quality TB and MDR-TB Services, Laboratory Quality Assurance, Development of cPMDT Standard Operating Procedures, strengthening of social support services for MDR TB patients and strengthened support systems for the effective delivery of TB services at all levels.

TB CARE II mHealth Background

With the support of the USAID TB CARE II project, the National Tuberculosis Control Program (NTP) in Bangladesh initiated a Community-based Programmatic Management of Drug Resistance Tuberculosis (cPMDT) program to treat DR TB in 2011. The cPMDT program requires an initial 1-2 months of hospitalization for DR TB patients who are then transitioned to community-based care, allowing patients to receive DR TB treatment in their own community. After the introduction of cPMDT, a large number of DR TB patients are now being discharged after a short stay in the hospital. At the community level, these patients continue their treatment under the supervision of specially trained DR TB DOT (directly observed treatment) providers. Treatment for DR TB requires a complex drug regimen which needs to be maintained over years. The TB CARE II project has developed and introduced a TB mHealth application which is designed to support the DOT providers to ensure quality DOT, assist to quickly identify drug-related side effects and link patients to treatment, and above all assist in patient management by facilitating documentation of the management procedures. The mHealth application is a web-based monitoring tool which allows DOT providers and managers to keep track of services delivered and organize an electronic record of treatment history of the DR TB patients. This system is designed to get input from mobile devices used by the DOT providers (Smartphone) through a GPS enabled the mobile application.

News Related to TB and Bangladesh

TB CARE II PROJECT OVERVIEW

The USAID TB CARE II Project, a five-year project implemented by a wide consortium of health and development organizations including and led by University Research Co., LLC (URC), began in 2010 with the aim of complementing and building upon existing and planned projects in the Bureau for Global Health to provide global leadership and support to National TB Programs and other in-country partners. Since then, the project team has

TB CARE II BANGLADESH – PROJECT OVERVIEW

Over the past 20 years, Bangladesh has made significant progress in detecting, diagnosing, and treating Tuberculosis (TB).  Despite this progress, TB remains a significant threat to people living in the country.  The USAID-funded TB CARE II Bangladesh project provides leadership and support to the National Tuberculosis Control Program (NTP) and local partners to increase access to high-quality treatment services in the effort to stop the spread of TB.  As

TB CARE II INTRODUCES TOOLKIT TO ADDRESS TIMELY TB CASE DETECTION AND TREATMENT

An effective tuberculosis (TB) control program requires early diagnosis and immediate initiation into treatment to reduce transmission.  In 2011, recognizing this fact, the USAID funded TB CARE II Project developed a framework for analyzing TB delay along with a set of tools to collect data on patient delays. TB CARE II then conducted field assessments using these tools in two high-burden TB countries— Bangladesh and Swaziland—in order to identify specific

TB CARE II – QUALITY IMPROVEMENT HANDBOOK FOR TB AND MDR-TB PROGRAMS

In recent years, national health programs have expanded their focus to include not only improving access to care, but also improving the quality of care received by patients and communities. As part of quality assurance for many clinical diseases, including tuberculosis (TB), international and national evidence-based standards and guidelines have been developed. Having explicit standards and guidelines helps ensure high-quality care, better health outcomes, and cost-effective treatments. In addition, they

TB CARE II BANGLADESH: CHANGING LIVES OF MDR TB PATIENTS

Improving management of Multi-Drug-resistant TB (MDR TB) is a special focus of the TB CARE II project. It is estimated that there are 3,800 MDR TB cases annually in Bangladesh. A large proportion of these cases remain undetected and untreated, potentially increasing the risk of infection in the community. It is not possible to combat the threat of MDR TB without a synchronized effort to expand national capacity both

TB CARE II BANGLADESH: INFOGRAPHIC

  Bangladesh is a low-income country with the population of 150.5 million. TB remains a major public health problem in Bangladesh: the country is among both high TB and high MDR-TB burden countries. More than 170,000 cases of TB including 106,790 smear positives were notified in 2012. Approximately, 70,000 people die from TB every year. The estimated MDR-TB burden is 1.4% among the new and 29% among the retreatment cases.